Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 12.90
+0.30 (2.38%)
Apr 24, 2025, 1:28 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 5.42 billion as of April 24, 2025. Its market cap has decreased by -17.52% in one year.
Market Cap
5.42B
Enterprise Value
5.24B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.90
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 5.42B, an increase of 6.21%. That is a compound annual growth rate of 2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 5.42B | -1.41% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 160.86B |
| Caliway Biopharmaceuticals | 93.07B |
| Bora Pharmaceuticals Co., LTD. | 67.36B |
| Lotus Pharmaceutical | 54.79B |
| Polaris Group | 28.88B |
| Oneness Biotech | 28.11B |
| Pegavision | 25.35B |
| Lumosa Therapeutics | 24.91B |